Astellas Pharma Inc
(OTCPK:ALPMF)
$
11.095
-0.0325 (-0.29%)
Market Cap: 19.93 Bil
Enterprise Value: 24.15 Bil
PE Ratio: 54.12
PB Ratio: 2.00
GF Score: 82/100 Q2 2025 Astellas Pharma Inc Earnings Presentation Transcript
Oct 30, 2024 / NTS GMT
Release Date Price:
$12
(+8.60%)
Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & IR Officer
Presentation
Oct 30, 2024 / NTS GMT
=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & IR Officer
* Naoki Okamura
Astellas Pharma Inc - President, Chief Executive Officer, Representative Director
* Claus Zieler
Astellas Pharma Inc - Chief Commercial Officer
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc. - Analyst
* Seiji Wakao
JPMorgan Securities Japan Co., Ltd - Analyst
* Shinichiro Muraoka
JPMorgan Securities Japan Co., Ltd - Analyst
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot